Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
TENCENT
00700
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 5.88%9.58B | 6.38%5.89B | 2.58%2.74B | 30.98%15.52B | 14.20%9.04B | 13.15%5.54B | 15.43%2.67B | 35.39%11.85B | 37.34%7.92B | 45.25%4.89B |
| Refunds of taxes and levies | 5.07%191.36M | 48.73%128.68M | 176.40%87.93M | 8.93%243.7M | -6.48%182.12M | -7.80%86.52M | -24.28%31.81M | 53.91%223.73M | 23.37%194.75M | -21.89%93.84M |
| Cash received from interests, fees and commissions | -84.06%1.2M | -93.58%371.77K | -91.22%371.77K | -83.06%8.2M | -75.71%7.55M | -65.55%5.79M | --4.24M | -42.92%48.39M | -53.78%31.08M | -63.26%16.81M |
| Cash received relating to other operating activities | 14.59%636.13M | 0.37%364.54M | 24.64%204.56M | 55.62%587.69M | 43.30%555.13M | 72.78%363.2M | -14.97%164.12M | 84.90%377.64M | 66.26%387.39M | 75.67%210.21M |
| Cash inflows from operating activities | 6.29%10.4B | 6.53%6.38B | 5.62%3.03B | 30.89%16.36B | 14.72%9.79B | 14.92%5.99B | 12.64%2.87B | 36.07%12.5B | 37.08%8.53B | 42.68%5.21B |
| Goods services cash paid | 16.85%5.39B | 17.93%3.49B | 11.98%1.63B | 49.98%9.67B | -4.33%4.61B | 0.69%2.96B | 10.90%1.45B | 28.71%6.45B | 36.32%4.82B | 35.87%2.94B |
| Staff behalf paid | 9.35%1.83B | 8.92%1.25B | 8.07%658.77M | 22.76%2.29B | 25.95%1.67B | 31.46%1.14B | 44.22%609.6M | 38.99%1.86B | 43.12%1.33B | 42.87%870.78M |
| All taxes paid | -1.58%808.8M | -2.21%516.22M | 34.34%269.29M | 16.64%987.64M | 26.77%821.75M | 31.56%527.91M | 5.21%200.46M | 39.81%846.73M | 27.35%648.22M | 29.48%401.26M |
| Cash paid relating to other operating activities | 16.13%1.92B | 8.15%1.19B | 22.98%627.37M | 9.51%1.57B | 14.71%1.65B | 33.38%1.1B | 34.16%510.13M | 42.95%1.43B | 40.29%1.44B | 28.24%823.59M |
| Cash outflows from operating activities | 13.55%9.95B | 12.40%6.44B | 14.76%3.18B | 37.05%14.52B | 6.32%8.76B | 13.82%5.73B | 20.38%2.77B | 33.08%10.6B | 37.29%8.24B | 35.17%5.04B |
| Net cash flows from operating activities | -55.50%458.01M | -122.77%-59.26M | -249.41%-148.43M | -3.43%1.84B | 250.48%1.03B | 45.96%260.24M | -59.69%99.35M | 55.52%1.9B | 31.55%293.66M | 350.23%178.29M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 1,793.84%5.24B | 2,252.60%5.25B | 3,672.79%3.59B | 36.57%1.55B | -11.24%276.87M | 4.72%223.32M | -11.47%95.21M | -13.80%1.13B | -57.24%311.92M | -56.65%213.26M |
| Cash received from returns on investments | -31.07%55.17M | -44.48%26.77M | -90.10%3.7M | 47.16%98.92M | 47.56%80.04M | 17.38%48.21M | --37.39M | -20.11%67.22M | 18.25%54.24M | -20.09%41.07M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 12,678.37%14.36M | 11,734.82%14.36M | ---- | -48.08%1.42M | -31.87%112.37K | -27.20%121.3K | --60.23K | 994.79%2.74M | --164.93K | --166.62K |
| Net cash received from disposal of subsidiaries and other business units | --3M | ---- | --3M | ---- | ---- | ---- | ---- | --40M | ---- | ---- |
| Cash inflows from investing activities | 1,389.00%5.32B | 1,849.16%5.29B | 2,612.76%3.6B | 32.56%1.65B | -2.54%357.02M | 6.74%271.65M | 23.35%132.66M | -11.14%1.24B | -52.76%366.32M | -53.16%254.5M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -14.46%607.53M | 29.78%503.24M | 6.90%273.48M | 87.90%1.04B | 99.09%710.23M | 83.25%387.75M | 191.99%255.83M | 37.64%555.91M | 25.52%356.74M | 33.01%211.6M |
| Cash paid to acquire investments | 1,508.54%4.59B | 2,546.64%4.56B | 11,259.61%3.86B | 172.42%2.63B | 126.65%285.41M | 229.81%172.21M | --34.02M | 42.81%965.34M | -25.58%125.92M | -76.77%52.21M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | -99.19%2.32M | -99.19%2.32M | -99.19%2.32M | ---- | -41.80%286.14M | -41.76%286.34M | -41.76%286.34M |
| Cash outflows from investing activities | 420.91%5.2B | 800.08%5.06B | 1,327.66%4.14B | 103.43%3.68B | 29.77%997.95M | 2.20%562.28M | 230.82%289.85M | 15.01%1.81B | -18.63%769M | -37.16%550.15M |
| Net cash flows from investing activities | 118.35%117.61M | 180.49%233.92M | -243.08%-539.29M | -260.16%-2.03B | -59.17%-640.93M | 1.70%-290.63M | -888.42%-157.19M | -229.45%-562.74M | -137.31%-402.68M | 10.99%-295.66M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 7.73%126.56M | -13.97%64.25M | 43.75%35M | 144.73%124.77M | 297.56%117.48M | 178.97%74.68M | -5.48%24.35M | -59.62%50.98M | -48.72%29.55M | -53.54%26.77M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 144.73%124.77M | -22.17%23M | -81.32%5M | ---- | 35.60%50.98M | --29.55M | --26.77M |
| Cash from borrowing | 176.70%1.55B | 400.88%1.3B | ---- | 6.75%4B | -54.97%559.45M | -57.57%259.98M | 16.69%259.98M | 38.86%3.75B | -48.30%1.24B | -67.93%612.79M |
| Cash received relating to other financing activities | -39.40%190.39M | -80.55%99.87M | 74.23%151.82M | --43.49M | -40.98%314.18M | 97.14%513.52M | -13.91%87.14M | ---- | -37.18%532.32M | -46.40%260.48M |
| Cash inflows from financing activities | 88.17%1.86B | 72.88%1.47B | -49.71%186.82M | 9.75%4.17B | -45.07%991.11M | -5.76%848.18M | 6.20%371.47M | 30.51%3.8B | -45.46%1.8B | -63.33%900.04M |
| Borrowing repayment | -5.35%2.51B | -5.46%1.91B | -99.47%1.37M | 80.66%3.45B | 47.93%2.65B | 121.12%2.02B | -16.96%260M | -46.60%1.91B | -34.32%1.79B | -55.63%913.1M |
| Dividend interest payment | 40.25%1.33B | 36.68%1.29B | 28.90%16.69M | 81.01%956.28M | 80.50%945.55M | 81.34%940.91M | 73.49%12.95M | 5.89%528.31M | 3.91%523.84M | 5.33%518.88M |
| -Including:Cash payments for dividends or profit to minority shareholders | 278.30%6.93M | -0.33%1.83M | ---- | -80.48%3.16M | --1.83M | --1.83M | ---- | 386.16%16.18M | ---- | ---- |
| Cash payments relating to other financing activities | -51.51%295.76M | -81.96%128.11M | -76.67%72.85M | 110.89%391.19M | 44.68%609.96M | 226.01%710.18M | 159.56%312.31M | 220.81%185.5M | -51.29%421.6M | -55.65%217.84M |
| Cash outflows from financing activities | -1.79%4.13B | -9.46%3.32B | -84.47%90.92M | 82.87%4.8B | 53.67%4.2B | 122.46%3.67B | 32.75%585.26M | -36.52%2.62B | -33.20%2.74B | -45.76%1.65B |
| Net cash flows from financing activities | 29.54%-2.26B | 34.21%-1.86B | 144.86%95.91M | -153.57%-629.21M | -244.92%-3.21B | -276.37%-2.82B | -134.64%-213.79M | 196.06%1.17B | -18.29%-931.53M | -27.69%-749.78M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -26.25%-38.39M | 54.44%-19.45M | 391.90%48.56M | -6,937.28%-82.22M | -24.98%-30.41M | -307.43%-42.69M | -412.33%-16.64M | 41.85%-1.17M | -932.29%-24.33M | -206.29%-10.48M |
| Net increase in cash and cash equivalents | 39.53%-1.73B | 41.23%-1.7B | -88.45%-543.26M | -135.91%-901.99M | -168.13%-2.86B | -229.87%-2.9B | -267.59%-288.27M | 1,552.63%2.51B | -45.67%-1.06B | 10.51%-877.62M |
| Add:Begin period cash and cash equivalents | -17.89%4.14B | -17.89%4.14B | -17.89%4.14B | 99.26%5.04B | 99.26%5.04B | 99.26%5.04B | 99.80%5.04B | -6.40%2.53B | -6.40%2.53B | -6.40%2.53B |
| End period cash equivalent | 10.36%2.41B | 13.58%2.44B | -24.33%3.6B | -17.89%4.14B | 49.23%2.19B | 29.91%2.15B | 76.36%4.75B | 99.26%5.04B | -25.69%1.47B | -4.05%1.65B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.